Trial Profile
A Study Assessing Impact of Insulin Degludec (IDeg) on Quality of Life (QOL) in Patients with Type 2 Diabetes Mellitus (T2DM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2021
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2021 Results published in the Quality of Life Research
- 21 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.